Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency.
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
To determine whether hyperandrogenism caused by an inborn error of adrenal steroidogenesis could produce insulin resistance, we examined insulin sensitivity in females with 21-hydroxylase deficiency. Minimal modelling was used to analyze the results of tolbutamide-modified, frequently sampled, iv glucose tolerance testing. Insulin sensitivity [Si; (min-1) (microU/mL)-1] was plotted against body mass index (BMI; defined as kilograms per m2). Six patients with nonclassical 21-hydroxylase deficiency (mean age, 27 yr; mean BMI, 23.2) underwent testing. None of these patients was in active puberty, nor was any patient being treated with glucocorticoids at the time of the study. Twelve eumenorrheic nonhyperandrogenic young adult female control subjects (mean age, 27 yr; mean BMI, 22.4) were also tested. The basal 17-hydroxyprogesterone concentration, but not the total serum testosterone level, was significantly different in the two groups (mean +/- SEM, 11,987 +/- 2,761 vs. 4,059 +/- 802 pmol/L; P < 0.05). As a group the patients' Si values were significantly lower than those of the controls (mean +/- SEM, 4.1 +/- 0.6 vs. 9.7 +/- 1.2; P < 0.05). There was no correlation between Si and basal serum 17-hydroxyprogesterone, testosterone, delta 4-androstenedione, or dehydroepiandrosterone. We conclude that chronic hypersecretion of androgen precursors due to an inborn error of metabolism can induce a reduction in insulin sensitivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“suggesting insulin insensitivity.”
In the citing paper
“This difference was not statistically significant but suggests a degree of insulin resistance previously reported in patients with CAH (19,25).”
Citations
Cites
Impaired Insulin Action in Puberty
Amiel, S. A., Sherwin, R. S., Simonson, D. C., Lauritano, A. A., & Tamborlane, W. V. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607243150402 · Cited by 958
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
BURGHEN, G. A., GIVENS, J. R., & KITABCHI, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919
Bergman, R. N., Prager, R., Volund, A., & Olefsky, J. M. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112886 · Cited by 772
DUNAIF, A., GRAF, M., MANDELI, J., LAUMAS, V., & DOBRJANSKY, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-499 · Cited by 586
The Gonadotropic Function of Insulin*
PORETSKY, L., & KALIN, M. F. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-132 · Cited by 447
NESTLER, J. E., BARLASCINI, C. O., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., CLORE, J. N., & BLACKARD, W. G. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-6-1027 · Cited by 338
The Effect of Growth Hormone on Glucose Metabolism and Insulin Secretion in Man*
BRATUSCH-MARRAIN, P. R., SMITH, D., & DEFRONZO, R. A. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-5-973 · Cited by 321
PANG, S., HOTCHKISS, J., DRASH, A. L., LEVINE, L. S., & NEW, M. I. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-1003 · Cited by 293
Self-citationDunaif, A., & Graf, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113864 · Cited by 204
Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia
KOHN, B., LEVINE, L. S., POLLACK, M. S., PANG, S., LORENZEN, F., LEVY, D., LERNER, A. J., RONDANINI, G. F., DUPONT, B., & NEW, M. I. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-5-817 · Cited by 204
Self-citation
Cited by
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
“However, it has been suggested that in women with CAH, the hyperandrogenemia also leads to a decrease in insulin sensitivity (253, 254), making distinction more difficult.”
BackgroundAzziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Self-citationCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
“Moreover, a significant reduction in insulin sensitivity, although not clinical diabetes, is found among young women with nonclassic CAH as compared with controls of similar age and weight (103).”
BackgroundSelf-citationTransient receptor potential M3 channels are ionotropic steroid receptors in pancreatic β cells
Wagner, T. F. J., Loch, S., Lambert, S., Straub, I., Mannebach, S., Mathar, I., Düfer, M., Lis, A., Flockerzi, V., Philipp, S. E., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1801 · Cited by 392
Sex steroids and insulin resistance
LIVINGSTONE, C., & COLLISON, M. (2002) · Clinical Science · doi:10.1042/cs1020151 · Cited by 309
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Self-citationIdentifying Children at Risk for Polycystic Ovary Syndrome
Rosenfield, R. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2012 · Cited by 288
“Insulin resistance has been reported in nonobese females with nonclassic CAH before initiating glucocorticoid therapy (29).”
BackgroundAzziz, R., Hincapie, L. A., Knochenhauer, E. S., Dewailly, D., Fox, L., & Boots, L. R. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00383-0 · Cited by 244
Steroid 11β- hydroxylase deficiency congenital adrenal hyperplasia
Nimkarn, S., & New, M. I. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.01.002 · Cited by 237
Self-citationCarmina, E., Dewailly, D., Escobar-Morreale, H. F., Kelestimur, F., Moran, C., Oberfield, S., Witchel, S. F., & Azziz, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx014 · Cited by 201
Corbould, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07070 · Cited by 184
“Untreated women with androgen excess due to non-classic congenital adrenal hyperplasia (21-hydroxylase deficiency) have reduced insulin sensitivity (Speiser et al. 1992, Saygili et al. 2005).”
BackgroundCharmandari, E., Weise, M., Bornstein, S. R., Eisenhofer, G., Keil, M. F., Chrousos, G. P., & Merke, D. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8456 · Cited by 164
“Although a fall in insulin sensitivity has been previously described in adults with nonclassic (late-onset) CAH (46), to our knowledge, there are no reports on alterations in insulin sensitivity/resistance in patients with the classic form of the disease.”
BackgroundCongenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 159
Corbould, A. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.872 · Cited by 144
Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D
Sacerdote, A. S., Dave, P., Lokshin, V., & Bahtiyar, G. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1201-y · Cited by 174
Ibanez, L., Potau, N., Zampolli, M., Prat, N., Virdis, R., Vicens-Calvet, E., & Carrascosa, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772605 · Cited by 138
Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues
Ogilvie, C. M., Crouch, N. S., Rumsby, G., Creighton, S. M., Liao, L., & Con Way, G. S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02410.x · Cited by 136
Management of adolescents with congenital adrenal hyperplasia
Merke, D. P., & Poppas, D. P. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70138-4 · Cited by 134
Approach to the Adult with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Merke, D. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2417 · Cited by 132
Bremer, A. A., & Miller, W. L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.091 · Cited by 151
Oppenheimer, E., Linder, B., & DiMartino-Nardi, J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7852529 · Cited by 128
Falhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127
Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Mitrakou, A., Hennes, M. M. I., Platanisiotis, D., Kaklas, N., Spina, J., Georgiadou, E., Hoffmann, R. G., Kissebah, A. H., & Raptis, S. A. (1995) · Metabolism · doi:10.1016/0026-0495(95)90062-4 · Cited by 128
Prenatal testosterone excess programs reproductive and metabolic dysfunction in the female
Padmanabhan, V., Manikkam, M., Recabarren, S. E., & Foster, D. L. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.016 · Cited by 132
Long-Term Outcome of Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Bachelot, A., Plu-Bureau, G., Thibaud, E., Laborde, K., Pinto, G., Samara, D., Nihoul-Fékété, C., Kuttenn, F., Polak, M., & Touraine, P. (2007) · Hormone Research in Paediatrics · doi:10.1159/000098017 · Cited by 106
Health Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Reisch, N., Arlt, W., & Krone, N. (2011) · Hormone Research in Paediatrics · doi:10.1159/000327794 · Cited by 106
Clinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106
“IV glucose tolerance test [96], HbA1c [9], or forearm model combined with local indirect calorimetry [97] have also been used.”
MethodMANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
Markopoulos, M. C., Kassi, E., Alexandraki, K. I., Mastorakos, G., & Kaltsas, G. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0468 · Cited by 105
Falhammar, H., Filipsson Nyström, H., Wedell, A., & Thorén, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0877 · Cited by 103
Nonclassic Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/625105 · Cited by 101
CONGENITAL ADRENAL HYPERPLASIA OWING TO 21-HYDROXYLASE DEFICIENCY
Speiser, P. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70018-5 · Cited by 109
Self-citationGestational Hyperandrogenism in Developmental Programming
Hakim, C., Padmanabhan, V., & Vyas, A. K. (2017) · Endocrinology · doi:10.1210/en.2016-1801 · Cited by 97
Polycystic Ovary Syndrome in the Pediatric Population
Bremer, A. A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0039 · Cited by 94
Fertility in Women With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
.L. Stikkelbroeck, N. M. M., .M. Hermus, A. R. M., . Braat, D. D. M., & Otten, B. J. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000062966.93819.5b · Cited by 95
Mooij, C. F., Kroese, J. M., Claahsen‐van der Grinten, H. L., Tack, C. J., & Hermus, A. R. M. M. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03690.x · Cited by 92
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
Trapp, C. M., & Oberfield, S. E. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.009 · Cited by 81
Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism
Knochenhauer, E. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.479 · Cited by 81
Saygılı, F., Oge, A., & Yilmaz, C. (2005) · Hormone Research in Paediatrics · doi:10.1159/000086363 · Cited by 75
Williams, R. M., Deeb, A., Ong, K. K., Bich, W., Murgatroyd, P. R., Hughes, I. A., & Acerini, C. L. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03587.x · Cited by 69
Statins for women with polycystic ovary syndrome not actively trying to conceive
Raval, A. D., Hunter, T., Stuckey, B., & Hart, R. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008565.pub2 · Cited by 68
Naftalin, R. J., Afzal, I., Cunningham, P., Halai, M. M., Ross, C. L., Salleh, N., & Milligan, S. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705460 · Cited by 70
Zhang, H., Yang, J., Zhang, M., Liu, C., Xu, M., Li, X., Yang, S.-Y., & Li, X.-Y. (2010) · Endocrine · doi:10.1007/s12020-010-9382-9 · Cited by 64
Steroid 21 Hydroxylase Deficiency Congenital Adrenal Hyperplasia
Nimkarn, S., Lin‐Su, K., & New, M. I. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.07.012 · Cited by 67
Self-citationInsulin resistance improves in hyperandrogenic women treated with Lupron
Elkind-Hirsch, K. E., Valdés, C. T., & Malinak, L. R. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56213-x · Cited by 67
Adult Consequences of Congenital Adrenal Hyperplasia
Arlt, W., & Krone, N. (2007) · Hormone Research in Paediatrics · doi:10.1159/000110615 · Cited by 58
Livadas, S., & Bothou, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00366 · Cited by 57
“These data, in conjunction with a few studies that indicate the presence of insulin insensitivity, suggest an unfavorable metabolic profile that could be pathophysiologically explained by the effect of elevated androgen concentrations and/or as a result of glucocorticoid therapy (42, 43).”
ResultSteroid 21 hydroxylase deficiency congenital adrenal hyperplasia
Nimkarn, S., Lin-Su, K., & New, M. I. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.08.001 · Cited by 52
Self-citationGreen-Golan, L., Yates, C., Drinkard, B., VanRyzin, C., Eisenhofer, G., Weise, M., & Merke, D. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0493 · Cited by 50
HAUTANEN, A., RÄIKKÖNEN, K., & CREUTZ, H. A. (1997) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1997.tb00002.x · Cited by 51
Pignatelli, D. (2013) · Frontiers of Hormone Research · doi:10.1159/000342179 · Cited by 44
Statins in the Treatment of Polycystic Ovary Syndrome
Kodaman, P. H., & Dulęba, A. J. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-992933 · Cited by 48
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Effect of dehydroepiandrosterone on glucose uptake in cultured human fibroblasts
Nakashima, N., Haji, M., Sakai, Y., Ono, Y., Umeda, F., & Nawata, H. (1995) · Metabolism · doi:10.1016/0026-0495(95)90065-9 · Cited by 47
Kim, M., & Merke, D. (2009) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1225259 · Cited by 41
Ghizzoni, L. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.601 · Cited by 40
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
Adriaansen, B. P. H., Schröder, M. A. M., Span, P. N., Sweep, F. C. G. J., van Herwaarden, A. E., & der Grinten, H. L. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064024 · Cited by 51
Classical Forms of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Adults
Bachelot, A., Chakthoura, Z., Rouxel, A., Dulon, J., & Touraine, P. (2008) · Hormone Research in Paediatrics · doi:10.1159/000113020 · Cited by 37
Taylor, A. E. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70239-x · Cited by 37
Long-term consequences of childhood-onset congenital adrenal hyperplasia
White, P. C., & Speiser, P. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0198 · Cited by 40
Self-citationImproda, N., Barbieri, F., Ciccarelli, G. P., Capalbo, D., & Salerno, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00212 · Cited by 34
Congenital adrenal hyperplasia
Dessinioti, C., & Katsambas, A. (2009) · Dermato-Endocrinology · doi:10.4161/derm.1.2.7818 · Cited by 38
The pathogenesis of polycystic ovary syndrome: Lessons from ovarian stimulation studies
Barnes, R. B. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350782 · Cited by 37
Insulin resistance and the polycystic ovary syndrome
Hao, G. (2005) · Journal of reproductive medicine · Cited by 33
Bahtiyar, G., Weiss, K., & Sacerdote, A. S. (2007) · Endocrine Practice · doi:10.4158/ep.13.6.601 · Cited by 31
Al‐Kofahi, M., AHMED, M. A., Jaber, M. M., Tran, T. N., Willis, B. A., Zimmerman, C. L., Gonzalez‐Bolanos, M. T., Brundage, R. C., & Sarafoglou, K. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14470 · Cited by 31
Sarafoglou, K., Merke, D. P., Reisch, N., der Grinten, H. L. C., Falhammar, H., & Auchus, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad134 · Cited by 35
HMG-CoA Reductase Inhibitors: Do They Have Potential in the Treatment of Polycystic Ovary Syndrome?
Kodaman, P. H., & Dulęba, A. J. (2008) · Drugs · doi:10.2165/00003495-200868130-00001 · Cited by 36
Falhammar, H., Thoren, M., & Hagenfeldt, K. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345586 · Cited by 32
Congenital adrenal hyperplasia: Transition from childhood to adulthood
Speiser, P. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343913 · Cited by 31
Self-citationLewis, V. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70182-0 · Cited by 34
Polycystic Ovary Syndrome in Adolescence
Baumann, E. E., & Rosenfield, R. L. (2002) · The Endocrinologist · doi:10.1097/00019616-200207000-00011 · Cited by 30
Secondary forms of polycystic ovary syndrome
Kaltsas, G., Isidori, A. M., BESSER, G. M., & Grossman, A. B. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.05.009 · Cited by 28
Clustering of Cardiovascular Risk Factors Associated With the Insulin Resistance Syndrome
Zanolin, M. E., Tosi, F., Zoppini, G., Castello, R., Spiazzi, G., Dorizzi, R. M., Muggeo, M., & Moghetti, P. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1478 · Cited by 25
Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
Krysiak, R. G., der Grinten, H. L. C., Reisch, N., Touraine, P. A., & Falhammar, H. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae026 · Cited by 26
Delai, A., Gomes, P. M., Foss‐Freitas, M. C., Elías, J., Antonini, S. R. R., de Castro, M., Moreira, A. C., & Mermejo, L. M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab767 · Cited by 25
Steroid Metabolomic Signature of Insulin Resistance in Childhood Obesity
Gawlik, A., Shmoish, M., Hartmann, M. F., Wudy, S. A., & Hochberg, Z. (2019) · Diabetes Care · doi:10.2337/dc19-1189 · Cited by 27
Pathogenesis and treatment of hirsutism in late-onset congenital adrenal hyperplasia
Carmina, E. (1995) · Reproductive Medicine Review · doi:10.1017/s0962279900000569 · Cited by 23
Kroese, J. M., Mooij, C. F., van der Graaf, M., Hermus, A. R., & Tack, C. J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0523 · Cited by 25
Sarafoglou, K., Gonzalez‐Bolanos, M. T., Zimmerman, C. L., Boonstra, T., Yaw Addo, O., & Brundage, R. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.424 · Cited by 20
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 34
Androgens and Therapeutic Aspects of Antiandrogens in Women
Diamanti‐Kandarakis, E., Tolis, G., & Dulęba, A. J. (1995) · Journal of the Society for Gynecologic Investigation · doi:10.1016/1071-5576(95)00002-v · Cited by 22
Neven, A. C. H., Mousa, A., Boyle, J. A., & Teede, H. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.993619 · Cited by 36
Insulin Resistance in Congenital Adrenal Hyperplasia is Compensated for by Reduced Insulin Clearance
de Oliveira, D. M., Tura, A., Vasques, A. C. J., Camilo, D. F., Lima, M. M. D. O., de Lemos‐Marini, S. H. V., Gonçalves, E. M., Guerra‐Júnior, G., & Geloneze, B. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab010 · Cited by 18
Hormonal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Bachelot, A., Chakhtoura, Z., Rouxel, A., Dulon, J., & Touraine, P. A. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.019 · Cited by 20
Non-classic adrenal hyperplasia in hyperandrogenism: A reappraisal
Morán, C., Knochenhauer, E. S., & Azziz, R. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350803 · Cited by 19
Past, Present and Future of Human Chromaffin Cells: Role in Physiology and Therapeutics
Pérez‐Alvarez, A., Hernández‐Vivanco, A., & Albillos, A. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9582-0 · Cited by 19
Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
Rosenfield, R. L., Barnes, R. B., & Ehrmann, D. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00133-5 · Cited by 17
Johannsen, T. H., Ripa, C. P. L., Carlsen, E., Starup, J., Nielsen, O. H., Schwartz, M., Drzewiecki, K. T., Mortensen, E. L., & Main, K. M. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/784297 · Cited by 26
Statins for women with polycystic ovary syndrome not actively trying to conceive
Raval, A. D., Hunter, T., Stuckey, B. G. A., & Hart, R. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008565 · Cited by 16
Kovanci, E., & Buster, J. E. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.068 · Cited by 17
Mapas-Dimaya, A. C., Agdere, L., Bahtiyar, G., Mejia, J. O., & Sacerdote, A. S. (2008) · Endocrine Practice · doi:10.4158/ep.14.7.889 · Cited by 12
Androgens and polycystic ovary syndrome
Alpañés, M., Fernández‐Durán, E., & Escobar-Morreale, H. F. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.85 · Cited by 17
Insulin Resistance Effects on Sex Hormones and Ovulation in the Polycystic Ovary Syndrome
Nestler, J. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_19 · Cited by 11
Publisher, B. S. (2006) · Current Vascular Pharmacology · doi:10.2174/157016106778521599 · Cited by 9
Insulin resistance: what is its role in the polycystic ovary syndrome?
Moghetti, P. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200212000-00002 · Cited by 14
Kalani, A., Thomas, N., Sacerdote, A. S., & Bahtiyar, G. (2013) · BMJ Case Reports · doi:10.1136/bcr-2012-008416 · Cited by 9
Hautanen, A., & Adlercreutz, H. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(96)00013-1 · Cited by 9
Geisthövel, F., Wacker, A., Brabant, G. E., Botsch, F., Maechtel, A., Wetzka, B., & Ochsner, A. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 10
Metadata
- Authors
- Speiser, P. W., Serrat, J., New, M. I., & Gertner, J. M.
- ORCID
- Speiser, P W
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1992-12
- Volume
- 75
- Issue
- 6
- Pages
- 1421-1424
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2068072549
- Cited by
- 143
- References
- 19
- Citations by year
- 2024: 2 · 2023: 5 · 2022: 1 · 2021: 5 · 2020: 1 · 2019: 6 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 7 · 2014: 4 · 2013: 6 · 2012: 3
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (RR06020, RR 47)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 00072)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- insulin resistance, adrenal hyperplasia, hyperandrogenism, insulin sensitivity, 17-hydroxyprogesterone, androgen precursors, body mass index, young adult women
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adult, Female, Humans, Insulin Resistance, Middle Aged, Gonadal Steroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.